Article History
Received: 17 October 2023
Accepted: 18 February 2024
First Online: 1 June 2024
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Mark D. Twite reports consulting fees from Vero Biotech Inc. Aaron W. Roebuck reports employment with and stock options in Vero Biotech Inc. Stephanie R. Anderson reports previous employment with Vero Biotech Inc. Patents are planned for the GENOSYL<sup>®</sup> Delivery System by Vero Biotech Inc. A Dräger Fabius GS Premium anesthesia machine was also provided by Dräger. The authors declare that the work described is original research that has not been published previously. All authors have approved the manuscript.